Astaxanthin and Hyaluronic Acid: Two Very Different Absorption Problems

Absorption Ingredient guide7 min read Aug 25, 2026Updated Aug 25, 2026

Two diverging absorption routes: a fat route into the lymph and a microbial route producing fragments

Astaxanthin and hyaluronic acid turn up in the same aisle, often in the same liposomal format, frequently in the same shopping basket. They have almost nothing in common. One is a fat that cannot get into water; the other is a water-loving polymer far too large to cross a gut wall in the first place. Their absorption problems are not variations on a theme. They are opposites.

That makes the pair a useful test of whether you have actually understood what a delivery system does. For one of them, a lipid carrier addresses the real bottleneck and the human data shows it. For the other, a lipid carrier is answering a question nobody asked — and the genuinely interesting mechanism involves your gut bacteria.

Astaxanthin behaves like an oil, because it is one

Astaxanthin is a red carotenoid pigment, produced commercially from the microalga Haematococcus pluvialis. Like other carotenoids it is strongly lipophilic — it dissolves in fat and effectively not at all in water. Everything about its absorption follows from that single property.

Its route in is the fat route. Astaxanthin has to be emulsified, incorporated into bile-salt micelles in the small intestine, absorbed into the cells of the intestinal lining, and then packaged into chylomicrons, which enter the lymphatic system before reaching the bloodstream. It is not absorbed as a molecule crossing a membrane so much as ferried in as cargo on the fat-digestion pathway.

Which has a blunt practical consequence: without fat present, much of the dose does not go anywhere. Carotenoid absorption depends on the fat in the meal it arrives with, and a dose taken in a fasted state or in a format that supplies no lipid of its own is substantially wasted. This is the least glamorous and most reliable piece of advice in the category.

What a lipid carrier is worth, in actual numbers

Because the bottleneck is solubilisation, a formulation that arrives pre-dissolved in lipid should help — and when this was tested directly in humans, it did. Thirty-two healthy volunteers took a single 40 mg dose of astaxanthin either in lipid-based formulations or as a commercially available supplement of algal extract and dextrin in a hard capsule. The best lipid formulation, based on glycerol mono- and di-oleate, produced roughly 3.7 times the plasma exposure of the capsule.

That study is from 2003, and it is worth noting that it compares a lipid vehicle against a dry powder capsule — a fairly generous comparison. But the mechanism and the result agree, which is more than can be said for several fashionable formats, and the direction has held up in the carotenoid literature since. If a compound's problem is that it will not dissolve, giving it something to dissolve in is not a marketing gimmick.

Two bottlenecks, two routes

The same shelf, entirely different absorption problems

Astaxanthin route per Mercke Odeberg et al., Eur J Pharm Sci 2003;19(4):299–304 and the carotenoid absorption literature; hyaluronic acid route and the ~0.2% oral bioavailability figure per Šimek et al., Carbohydrate Polymers 2023;313:120880. The diagram shows sequence, not quantities, apart from the labelled bioavailability value.

Hyaluronic acid has the opposite problem

Hyaluronic acid is a long, heavily charged sugar polymer. In the body it holds water in connective tissue and skin, which is why it is sold as a supplement at all. As something to swallow, it has a straightforward difficulty: it is enormous, and gut walls do not admit enormous charged molecules.

Reported oral bioavailability sits around 0.2%. Not 20% — nought point two. Whatever oral hyaluronic acid is doing, it is not arriving at your skin as intact hyaluronic acid, and any account of it that implies otherwise is describing a mechanism that does not exist.

The strange and rather elegant part is what does happen. Hyaluronic acid is not meaningfully broken down by your own gastric or intestinal enzymes — it survives them. What breaks it down is your gut microbiota, in the large intestine, cleaving the polymer into unsaturated oligosaccharides small enough that some fraction can be absorbed. Molecular weight decides the itinerary: high-molecular-weight material, roughly 100 kDa and above, passes the upper gut largely untouched, while lower-molecular-weight forms are taken up further down.

Which means the delivery system is bacterial, not pharmaceutical

Sit with the implication. For hyaluronic acid, the rate-limiting step is not stomach acid, not solubility, not transporter saturation. It is whether your particular microbial community contains organisms that can cut the polymer up — and that varies between people in ways no formulation controls.

So wrapping hyaluronic acid in a phospholipid shell does not address its bottleneck. The molecule was never being destroyed on the way in; it was being ignored. A liposome protects a payload from digestion, and hyaluronic acid's problem is the reverse of insufficient protection.

None of which means the ingredient is inert. It means the honest mechanism is indirect: whatever oral hyaluronic acid does is most plausibly done by its fragments and by whatever signalling follows, not by delivery of the intact polymer to distant tissue. That is a real hypothesis with real research behind it, and it is a very different claim from the one usually printed on the box. In the EU, health claims for hyaluronic acid are not authorised, and the reason is not bureaucratic obstruction — the evidence chain genuinely is not complete.

How to use each of them

Astaxanthin: take it with fat, and stop worrying about the format

A meal containing fat is doing most of the work. An oil-based softgel supplies its own lipid and is a sensible default; a dry powder taken with water on an empty stomach is the one combination clearly worth avoiding. Beyond that, the marginal differences between clever formats are much smaller than the difference between fed and fasted.

Hyaluronic acid: molecular weight is the specification that matters

If a label states a molecular weight, it is telling you something real about where in your gut the material will end up. If it only says "liposomal" or "high absorption," it is describing packaging for a molecule whose absorption is decided by microbes. Consistency over weeks makes more sense than chasing peak levels that were never going to appear.

Both: judge the ingredient, then the format — in that order

The useful question is always what specifically stops this compound being absorbed, and whether this format addresses that. Solubility problems respond to lipid carriers. Size and charge problems do not. A format that helps one ingredient tells you nothing about the next.

The bottom line

Astaxanthin is a solubility problem, and lipid delivery is a real answer to it — roughly a 3.7-fold difference in the human comparison, and a much larger practical difference between taking it with a meal and taking it without. Hyaluronic acid is a size problem, absorbed at around 0.2% and only after gut bacteria cut it down, which no wrapper changes. Same shelf, same adjective on the label, two completely unrelated mechanisms.

That is the argument for reading past the format. In Agen's range, liposomal astaxanthin uses phospholipid delivery for a compound with a genuine dispersal problem, while liposomal hyaluronic acid sits alongside collagen complex and the rest of the skin, hair and nails range — where the honest framing is a long-term habit, not a delivery breakthrough. For the mechanism behind all of these formats, see what your gut does to a liposome; for the ingredient with the strongest data, the vitamin C trials; and for the poorly-soluble plant compounds, quercetin and its rivals.

Language

Country/Region